![Agios Pharmaceuticals Inc](/common/images/company/L_0HB0.png)
Agios Pharmaceuticals Inc (0HB0)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -38.198 | -51.021 | -46.987 | -47.047 | -37.549 | 140.108 | -17.322 | -32.363 |
Return on Equity (%) | -56.407 | -85.73 | -65.102 | -61.966 | -62.954 | 189.741 | -19.375 | -36.833 |
Return on Invested Capital (%) | -65.861 | -115.492 | -103.865 | -89.335 | -80.263 | -60.55 | -43.089 | -50.174 |
Operating Margin (%) | -283.968 | -731.604 | -366.606 | -348.965 | -152.335 | 3919.947 | -1627.816 | -1312.635 |
Net Profit Margin (%) | -283.968 | -731.604 | -366.606 | -348.965 | -161.11 | 3875.281 | -1627.816 | -1312.635 |
Book Value Per Share | 8.493 | 7.691 | 11.809 | 9.364 | 5.765 | 23.778 | 20 | 14.511 |
Earnings Per Share | -4.701 | -6.445 | -5.944 | -6.016 | -4.724 | 29.534 | -4.212 | -6.3 |
Cash Per Share | 3.808 | 2.104 | 1.211 | 1.183 | 1.839 | 3.738 | 2.53 | 1.578 |
Working Capital Per Share | 11.167 | 7.175 | 8.937 | 7.585 | 7.826 | 18.486 | 13.992 | 13.703 |
Operating Profit Per Share | 1.655 | 0.881 | 1.597 | 1.705 | 2.892 | 0.749 | 0.228 | 0.428 |
EBIT Per Share | -4.701 | -6.445 | -5.944 | -6.016 | -4.724 | 29.77 | -4.212 | -6.3 |
EBITDA Per Share | -4.701 | -6.445 | -5.944 | -6.016 | -4.724 | 29.77 | -4.212 | -6.3 |
Free Cash Flow Per Share | -4.601 | -6.482 | -5.947 | -5.956 | -4.653 | 29.47 | -4.278 | -6.087 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 42,22M | 48,83M | 58,22M | 68,4M | 69,29M | 54,33M | 55,04M | N/A |
Capitalisation boursière | 4,77B |
Ratio cours/bénéfice | -5,46 |
Ratio prix/ventes | 71,72 |
Ratio prix/liquidités | 21,81 |
Ratio prix/valeur comptable | 2,37 |
Rendement de dividende | - |
Actions en circulation | 55,89M |
Volume moyen (1 semaine) | 51 |
Volume moyen (1 mois) | 226 |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 85,29 |
Plus bas sur 52 semaines | 85,29 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales